ID
24137
Description
Study ID: 100468 Clinical Study ID: AVA100468 Study Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Avandia XR,Rosiglitazone XR,Avandia Study Indication: Alzheimer's Disease Early Withdrawal
Keywords
Versions (1)
- 7/25/17 7/25/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 25, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Early Withdrawal GSK Rosiglitazone Alzheimer's disease 100468
Early Withdrawal GSK Rosiglitazone Alzheimer's disease 100468
- StudyEvent: ODM
Description
Visit Information
Alias
- UMLS CUI-1
- C0545082
Description
Investigator Instructions
Alias
- UMLS CUI-1
- C1442085
Description
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
Weight
Data type
float
Measurement units
- kg
Alias
- UMLS CUI [1]
- C0005910
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
float
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
float
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
float
Measurement units
- beats/minute
Alias
- UMLS CUI [1]
- C0018810
Description
Central Laboratory (Non Fasting Samples)
Alias
- UMLS CUI-1
- C1880016
Description
Pregnancy Test
Alias
- UMLS CUI-1
- C0032976
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Adverse Event
Alias
- UMLS CUI-1
- C0877248
Description
Adverse Event
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Physical Examination
Data type
text
Alias
- UMLS CUI [1]
- C0031809
Description
Pedal Oedema
Alias
- UMLS CUI-1
- C0574002
Description
Pedal Oedema: depth
Data type
integer
Alias
- UMLS CUI [1,1]
- C0574002
- UMLS CUI [1,2]
- C0205125
Description
Pedal Oedema: Site
Data type
integer
Alias
- UMLS CUI [1,1]
- C0574002
- UMLS CUI [1,2]
- C1515974
Description
Complete the Early Withdrawal ADAS-cog and CIBIC+ from the Rating Scale CRF, and record the results on the following pages.
Alias
- UMLS CUI-1
- C0681889
Description
Investigator Instructions
Alias
- UMLS CUI-1
- C1709896
- UMLS CUI-2
- C1320303
Similar models
Early Withdrawal GSK Rosiglitazone Alzheimer's disease 100468
- StudyEvent: ODM
C1442085 (UMLS CUI-2)
C1442085 (UMLS CUI [1,2])
C0205125 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,2])
C1320303 (UMLS CUI-2)
C1320303 (UMLS CUI [1,2])